Ralph Schiess

Dr. Ralph Schiess is a biochemist by training and received his Ph.D. from the ETH Zurich. During his doctoral studies his research was focusing on mass spectrometry based proteomics with a special interest in biomarker discovery. Since 2010, he is CEO and co-founder of ProteoMediX AG, a company dedicated to enable personalized cancer medicine by bringing together diagnosis and therapy.